128 related articles for article (PubMed ID: 31071370)
21. Increased Degree of Unsaturation in the Lipid of Antifungal Cationic Amphiphiles Facilitates Selective Fungal Cell Disruption.
Steinbuch KB; Benhamou RI; Levin L; Stein R; Fridman M
ACS Infect Dis; 2018 May; 4(5):825-836. PubMed ID: 29419285
[TBL] [Abstract][Full Text] [Related]
22. Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway.
Wang YJ; Li Q; Xiao HB; Li YJ; Yang Q; Kan XX; Chen Y; Liu XN; Weng XG; Chen X; Cai WY; Guo Y; Huang HF; Zhu XX
Drug Des Devel Ther; 2015; 9():5301-13. PubMed ID: 26445529
[TBL] [Abstract][Full Text] [Related]
23. Complex Mitochondrial Dysfunction Induced by TPP
Fuentes-Retamal S; Sandoval-Acuña C; Peredo-Silva L; Guzmán-Rivera D; Pavani M; Torrealba N; Truksa J; Castro-Castillo V; Catalán M; Kemmerling U; Urra FA; Ferreira J
Cells; 2020 Feb; 9(2):. PubMed ID: 32053908
[TBL] [Abstract][Full Text] [Related]
24. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
[TBL] [Abstract][Full Text] [Related]
25. Vitamin E succinate with multiple functions: A versatile agent in nanomedicine-based cancer therapy and its delivery strategies.
Liang L; Qiu L
Int J Pharm; 2021 May; 600():120457. PubMed ID: 33676991
[TBL] [Abstract][Full Text] [Related]
26. A novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex II.
Wang L; Zhang X; Cui G; Chan JY; Wang L; Li C; Shan L; Xu C; Zhang Q; Wang Y; Di L; Lee SM
Oncotarget; 2016 May; 7(22):32054-64. PubMed ID: 27081033
[TBL] [Abstract][Full Text] [Related]
27. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
28. Novel peptide-doxorubucin conjugates for targeting breast cancer cells including the multidrug resistant cells.
Soudy R; Chen C; Kaur K
J Med Chem; 2013 Oct; 56(19):7564-73. PubMed ID: 24028446
[TBL] [Abstract][Full Text] [Related]
29. Marine peptides in breast cancer: Therapeutic and mechanistic understanding.
Ahmed S; Mirzaei H; Aschner M; Khan A; Al-Harrasi A; Khan H
Biomed Pharmacother; 2021 Oct; 142():112038. PubMed ID: 34411915
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial fragmentation, elevated mitochondrial superoxide and respiratory supercomplexes disassembly is connected with the tamoxifen-resistant phenotype of breast cancer cells.
Tomková V; Sandoval-Acuña C; Torrealba N; Truksa J
Free Radic Biol Med; 2019 Nov; 143():510-521. PubMed ID: 31494243
[TBL] [Abstract][Full Text] [Related]
31. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
[TBL] [Abstract][Full Text] [Related]
32. Oxyresveratrol drives caspase-independent apoptosis-like cell death in MDA-MB-231 breast cancer cells through the induction of ROS.
Sunilkumar D; Drishya G; Chandrasekharan A; Shaji SK; Bose C; Jossart J; Perry JJP; Mishra N; Kumar GB; Nair BG
Biochem Pharmacol; 2020 Mar; 173():113724. PubMed ID: 31756327
[TBL] [Abstract][Full Text] [Related]
33. Cationic lipid-conjugated bis-arylidene oxindole derivatives as broad-spectrum breast cancer-selective therapeutics.
Yousuf M; Sridharan K; Mishra T; Mahadik NS; Banerjee R; Adhikari SS
Bioorg Chem; 2023 Apr; 133():106395. PubMed ID: 36753964
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrially targeted vitamin E succinate modulates expression of mitochondrial DNA transcripts and mitochondrial biogenesis.
Truksa J; Dong LF; Rohlena J; Stursa J; Vondrusova M; Goodwin J; Nguyen M; Kluckova K; Rychtarcikova Z; Lettlova S; Spacilova J; Stapelberg M; Zoratti M; Neuzil J
Antioxid Redox Signal; 2015 Apr; 22(11):883-900. PubMed ID: 25578105
[TBL] [Abstract][Full Text] [Related]
35. Development of new estradiol-cationic lipid hybrids: ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity.
Sudhakar G; Bathula SR; Banerjee R
Eur J Med Chem; 2014 Oct; 86():653-63. PubMed ID: 25222876
[TBL] [Abstract][Full Text] [Related]
36. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
37. Functionalization of peptide nucleolipid bioconjugates and their structure anti-cancer activity relationship studies.
Rana N; Cultrara C; Phillips M; Sabatino D
Bioorg Med Chem Lett; 2017 Sep; 27(17):4019-4023. PubMed ID: 28789897
[TBL] [Abstract][Full Text] [Related]
38. Nanoemulsion enhances α-tocopherol succinate bioavailability in rats.
Gao Y; Qi X; Zheng Y; Ji H; Wu L; Zheng N; Tang J
Int J Pharm; 2016 Dec; 515(1-2):506-514. PubMed ID: 27746330
[TBL] [Abstract][Full Text] [Related]
39. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
[TBL] [Abstract][Full Text] [Related]
40. Targeting mitochondrial function for the treatment of breast cancer.
Deus CM; Coelho AR; Serafim TL; Oliveira PJ
Future Med Chem; 2014 Sep; 6(13):1499-513. PubMed ID: 25365234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
